共 157 条
[1]
Conway G(2014)The polycystic ovary syndrome: a position statement from the European Society of Endocrinology Eur J Endocrinol 171 P1-29
[2]
Dewailly D(2018)Enlarged adipocytes in subcutaneous adipose tissue associated to hyperandrogenism and visceral adipose tissue volume in women with polycystic ovary syndrome Steroids 130 15-21
[3]
Diamanti-Kandarakis E(2013)Adipocyte biology in polycystic ovary syndrome Mol Cell Endocrinol 373 68-76
[4]
Echiburú B(2012)Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study Hum Reprod 27 541-549
[5]
Pérez-Bravo F(1999)Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity Biochem Biophys Res Commun 257 79-83
[6]
Galgani JE(2006)Upregulation of adiponectin receptor 1 and 2 mRNA and protein in adipose tissue and adipocytes in insulin-resistant women with polycystic ovary syndrome Diabetologia 49 2723-2728
[7]
Barber TM(2006)Adiponectin and resistin in PCOS: a clinical, biochemical and molecular genetic study Hum Reprod 21 2257-2265
[8]
Franks S(2015)Adipose tissue dysfunction, adipokines, and low-grade chronic inflammation in polycystic ovary syndrome Reproduction 149 R219-227
[9]
Panidis D(1998)Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome Eur J Endocrinol 138 269-274
[10]
Tziomalos K(2017)Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility Cochrane Database Syst Rev 11 CD003053-212